Date Added: 20/03/2017
Date Updated: 20/03/2017
Apalutamide for pre-metastatic hormone-refractory prostate cancer — add-on and substitute therapy
Specialties: Oncology & radiotherapy
Technology Type: Drugs
Stage of development: Investigational - phase III
Stage of EAA: Prioritised for assessment
Hormone-refractory (also termed castration resistant).
Stage of disease
Pre-metastatic, chemotherapy naïve.
Place in Treatment
Add-on and substitute.